Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients

Ann Rheum Dis. 2020 Mar;79(3):433-434. doi: 10.1136/annrheumdis-2019-216258. Epub 2019 Nov 19.
No abstract available

Keywords: B cells; autoimmune diseases; systemic vasculitis; treatment.

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Retroperitoneal Fibrosis / drug therapy*
  • Rituximab / therapeutic use*
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Rituximab